M Harrington1, K Butler, M Cafferkey. 1. Infectious Diseases Department, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.
Abstract
BACKGROUND AND AIMS: In anticipation of vaccine development this study sought to determine the incidence, disease burden and associated financial burden of rotavirus (RV) infection, in hospitalised children. METHODS: Prospective observational study in two Dublin paediatric centres. RESULTS: Of 663 confirmed infections, 485 (73%) patients were hospitalised with community acquired (CA) RV; 178 (27%) cases were hospital acquired (HA) RV. A total of 243 (50%) children were < 12 months of age, with peak incidence in the 6 to < 12 month age group. CA RV resulted in utilisation of 2,305 bed days, with a median bed stay of three days (range 1-91), representing a minimum cost of Euro176,637 per year to the hospitals. When nosocomial spread and secondary cases are included, this increases to Euro258,695 per year. CONCLUSION: CA RV infection accounted for 1% of all admissions during the study period at a minimum cost of Euro728.40 per case. A safe and effective vaccine could reduce morbidity and advantage children by allowing redeployment of healthcare resources to other critical areas.
BACKGROUND AND AIMS: In anticipation of vaccine development this study sought to determine the incidence, disease burden and associated financial burden of rotavirus (RV) infection, in hospitalised children. METHODS: Prospective observational study in two Dublin paediatric centres. RESULTS: Of 663 confirmed infections, 485 (73%) patients were hospitalised with community acquired (CA) RV; 178 (27%) cases were hospital acquired (HA) RV. A total of 243 (50%) children were < 12 months of age, with peak incidence in the 6 to < 12 month age group. CA RV resulted in utilisation of 2,305 bed days, with a median bed stay of three days (range 1-91), representing a minimum cost of Euro176,637 per year to the hospitals. When nosocomial spread and secondary cases are included, this increases to Euro258,695 per year. CONCLUSION: CA RV infection accounted for 1% of all admissions during the study period at a minimum cost of Euro728.40 per case. A safe and effective vaccine could reduce morbidity and advantage children by allowing redeployment of healthcare resources to other critical areas.
Authors: R I Glass; P E Kilgore; R C Holman; S Jin; J C Smith; P A Woods; M J Clarke; M S Ho; J R Gentsch Journal: J Infect Dis Date: 1996-09 Impact factor: 5.226
Authors: Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto Journal: BMC Infect Dis Date: 2012-03-19 Impact factor: 3.090
Authors: Susanne Hartwig; Matti Uhari; Marjo Renko; Perrine Bertet; Maria Hemming; Timo Vesikari Journal: BMC Health Serv Res Date: 2014-12-11 Impact factor: 2.655